IXICO

Precision in neuroscience

Biotechnology Research · London

About

IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.

Details

  • Website: https://www.ixico.com
  • Founded: 2004
  • Company Size: 92 employees
  • Headquarters: London
  • Specialties: Medical imaging, Clinical Trials, Alzheimer's Disease, Clinical Decision Support, Parkinson's Disease, Multiple Sclerosis, Progressive Supranuclear Palsy, Huntington's Disease, Cerebrovascular Disease, Neuroimaging, AI-driven nueroimaging, MRI, PET, SPECT